Early Body Temperature Targets and Relationship With Prognosis in Patients With Heat Stroke

NCT ID: NCT05921682

Last Updated: 2024-09-20

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

RECRUITING

Total Enrollment

100 participants

Study Classification

OBSERVATIONAL

Study Start Date

2023-05-28

Study Completion Date

2026-03-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The goal of this observational study is to explore the optimal target body temperature in first 24 hours and the relationship between body temperature and adverse outcomes of heat stroke.

The main questions it aims to answer are:

* the optimal target body temperature at 0.5 h, 2 h, and the lowest body temperature of heat stroke.
* the best body temperature at the cutting point of stop cooling.
* The relationship between the volume and speed of ice saline infusion and the cooling effect.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Heat Stroke

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Patients with heat stroke

Patients with heat stroke presenting to the emergency department at the study site

observation

Intervention Type OTHER

This study is an observational study. Patients will receive conventional cooling measures and organ function support.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

observation

This study is an observational study. Patients will receive conventional cooling measures and organ function support.

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* ≥ 18 years; ② diagnosed as heat stroke; ③ Informed consent from patients or family members.

Exclusion Criteria

* need immediate cardiopulmonary resuscitation; ② transferred from another hospital; ③ with severe underlying organ insufficiency; ④ pregnant women.
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Yiwu Central Hospital

OTHER

Sponsor Role collaborator

Jinhua People's Hospital

OTHER

Sponsor Role collaborator

Jinhua Municipal Central Hospital

OTHER

Sponsor Role collaborator

Dongyang People's Hospital

OTHER

Sponsor Role collaborator

Lanxi People's Hospital

OTHER

Sponsor Role collaborator

Second Affiliated Hospital, School of Medicine, Zhejiang University

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Lan Chen

Role: PRINCIPAL_INVESTIGATOR

Second Affiliated Hospital, School of Medicine, Zhejiang University

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Yiwu Central Hospital

Yiwu, Zhejiang, China

Site Status RECRUITING

Dongyang People's Hospital

Dongyang, , China

Site Status RECRUITING

The Second Affiliated Hospital of Zhejiang University School of Medicine

Hangzhou, , China

Site Status RECRUITING

Jinhua Municipal Central Hospital

Jinhua, , China

Site Status RECRUITING

Jinhua People's Hospital

Jinhua, , China

Site Status RECRUITING

Lanxi People's Hospital

Lanxi, , China

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

China

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Xiuqin Feng

Role: CONTACT

+8613757119151

Lan Chen

Role: CONTACT

+8613819987120

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Zhumei Gong

Role: primary

Shuying Xu

Role: primary

Xiuqin Feng

Role: primary

+8613757119151

Lan Chen

Role: backup

+8613819987120

Sunying Wu

Role: primary

Liyun Lu

Role: primary

Xiaoling Yang

Role: primary

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

2023-0517

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.